Gastrointestinal mucormycosis in immunocompromised hosts.
about
Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient.Gastrointestinal mucormycosis in an immunocompromised host.Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones.Recent advances in the understanding and management of mucormycosis
P2860
Gastrointestinal mucormycosis in immunocompromised hosts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Gastrointestinal mucormycosis in immunocompromised hosts.
@en
type
label
Gastrointestinal mucormycosis in immunocompromised hosts.
@en
prefLabel
Gastrointestinal mucormycosis in immunocompromised hosts.
@en
P2093
P2860
P356
P1433
P1476
Gastrointestinal mucormycosis in immunocompromised hosts
@en
P2093
Douglas R Osmon
Kelly A Cawcutt
M Veronica Dioverti
Randall C Walker
P2860
P304
P356
10.1111/MYC.12419
P577
2015-10-12T00:00:00Z